Tilson Financial Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$205K Buy
+1,500
New +$184K 0.06% 86
2026
Q1
Sell
-1,500
Closed -$246K 82
2025
Q4
$246K Hold
1,500
0.08% 78
2025
Q3
$201K Buy
+1,500
New +$182K 0.07% 77
2025
Q1
Sell
-1,500
Closed -$216K 75
2024
Q4
$216K Hold
1,500
0.09% 71
2024
Q3
$223K Buy
+1,500
New +$215K 0.1% 70
2024
Q2
Sell
-1,500
Closed -$276K 58
2024
Q1
$276K Hold
1,500
0.15% 59
2023
Q4
$270K Hold
1,500
0.17% 56
2023
Q3
$239K Buy
+1,500
New +$245K 0.19% 56
2023
Q2
Sell
-1,500
Closed -$253K 50
2023
Q1
$253K Hold
1,500
0.21% 53
2022
Q4
$254K Buy
+1,500
New +$272K 0.22% 53

Other funds holding RGEN

Tilson Financial Group's RGEN Position: Q2 2026 in Review

Tilson Financial Group opened a new position in Repligen (RGEN) in Q2 2026: 1,500 shares worth $205K. The stake represents 0.06% of the portfolio and ranks #86 among its holdings. This is a return to the name: Tilson Financial Group previously reported a position in RGEN as recently as Q4 2025.

Tilson Financial Group first reported a position in RGEN in Q4 2022 and has held it in 10 quarters since. The position peaked at $276K in Q1 2024. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Tilson Financial Group held 1,500 shares of Repligen worth $205K as of Q2 2026.
  • Repligen was a new Tilson Financial Group position in Q2 2026.
  • Repligen made up 0.06% of Tilson Financial Group's portfolio in Q2 2026, its #86 holding.
  • Tilson Financial Group first reported a position in Repligen in Q4 2022 and has held it in 10 quarters since.
  • Tilson Financial Group's Repligen position peaked at $276K in Q1 2024.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Tilson Financial Group's 13F filing for Q2 2026, filed 27 Jul 2026.